Is IDEXX Laboratories Stock Underperforming the Dow? The recent downturn in IDEXX Laboratories stock has sent shockwaves through the animal health industry, leaving investors and analysts scratching their heads.
With a market cap of $45. 7 billion, this veterinary diagnostics giant is no stranger to success. However, its struggles have raised questions about what's behind its underperformance.
A closer look at IDEXX's performance reveals a complex interplay of factors contributing to its decline.